TABLE 2.
Variables | Coefficient (β) | SE | Wald (χ2) | Significance | Odds Ratio | 95% CI |
---|---|---|---|---|---|---|
Nuclear pleomorphism* | 1.449 | 0.602 | 5.791 | 0.016 | 4.260 | 1.309–13.871 |
Cytoplasmic amphophilia | 1.395 | 0.832 | 2.809 | 0.094 | 0.248 | 0.049–1.267 |
N:C ≥ 50% | 1.012 | 0.599 | 2.851 | 0.091 | 2.751 | 0.850–8.904 |
Architecture: solid | 1.304 | 0.939 | 1.926 | 0.165 | 3.683 | 0.584–23.225 |
Architecture: scirrhous | 1.021 | 0.713 | 2.054 | 0.152 | 2.777 | 0.687–11.222 |
Architecture: acinar | 0.736 | 0.878 | 0.703 | 0.402 | 2.088 | 0.374–11.671 |
Macronucleoli | 0.570 | 0.622 | 0.841 | 0.359 | 1.768 | 0.523–5.979 |
Mitotic index | 0.337 | 0.596 | 0.320 | 0.571 | 1.401 | 0.436–4.507 |
CK19 labeling | −1.229 | 1.350 | 0.828 | 0.363 | 0.293 | 0.021–4.127 |
Intratumoral steatosis | −0.486 | 0.706 | 0.473 | 0.492 | 0.615 | 0.154–2.457 |
Intercept | −3.477 | 0.750 |
Nuclear pleomorphism is a statistically significant independent predictor of tumor recurrence after transplant.
95% CI indicates 95% confidence interval for estimated odds ratio; intercept, mathematical constant;
N:C, nuclear-to-cytoplasmic ratio; Wald, Wald test statistic.